Induction of cell death in ovarian cancer cells by doxorubicin and oncolytic vaccinia virus is associated with CREB3L1 activation

[1]  Jin Ye.  Transcription factors activated through RIP (regulated intramembrane proteolysis) and RAT (regulated alternative translocation) , 2020, The Journal of Biological Chemistry.

[2]  K. Hasegawa,et al.  Landscape of systemic therapy for ovarian cancer in 2019: Primary therapy , 2019, Cancer.

[3]  Yao Liang,et al.  Comparison of the MAID (AI) and CAV/IE regimens with the predictive value of cyclic AMP-responsive element-binding protein 3 like protein 1 (CREB3L1) in palliative chemotherapy for advanced soft-tissue sarcoma patients , 2019, Journal of Cancer.

[4]  S. Lockwood,et al.  Ovarian Cancer: An Integrated Review. , 2019, Seminars in oncology nursing.

[5]  D. Bartlett,et al.  Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics , 2019, Journal of Immunotherapy for Cancer.

[6]  C. Sotiriou,et al.  Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer , 2018, Oncogene.

[7]  B. Denard,et al.  CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy , 2018, BMC Cancer.

[8]  D. Sharma,et al.  Necroptosis: a regulated inflammatory mode of cell death , 2018, Journal of Neuroinflammation.

[9]  Y. Fong,et al.  A Novel Oncolytic Chimeric Orthopoxvirus Encoding Luciferase Enables Real-Time View of Colorectal Cancer Cell Infection , 2018, Molecular therapy oncolytics.

[10]  S. Wootton,et al.  Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies , 2018, The Journal of Immunology.

[11]  Daniel H. Miller,et al.  Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1 , 2017, Nature Communications.

[12]  E. Chiocca,et al.  Oncolytic Viruses in Cancer Treatment: A Review , 2017, JAMA oncology.

[13]  D. Bartlett,et al.  Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives , 2017, Front. Immunol..

[14]  R. Burger,et al.  Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  M. Opyrchal,et al.  Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy , 2016, Molecular therapy oncolytics.

[16]  N. Waterhouse,et al.  Detecting Cleaved Caspase-3 in Apoptotic Cells by Flow Cytometry. , 2016, Cold Spring Harbor protocols.

[17]  N. Waterhouse,et al.  Quantitation of Apoptosis and Necrosis by Annexin V Binding, Propidium Iodide Uptake, and Flow Cytometry. , 2016, Cold Spring Harbor protocols.

[18]  H. Lee,et al.  MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer , 2016, Breast Cancer Research and Treatment.

[19]  F. Vizeacoumar,et al.  Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers , 2016, Breast Cancer Research.

[20]  S. Cairo,et al.  Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer , 2015, British Journal of Cancer.

[21]  R. Sun,et al.  M1 of Murine Gamma-Herpesvirus 68 Induces Endoplasmic Reticulum Chaperone Production , 2015, Scientific Reports.

[22]  O. Maguire,et al.  Simultaneous assessment of NF-κB/p65 phosphorylation and nuclear localization using imaging flow cytometry. , 2015, Journal of immunological methods.

[23]  R. Collins,et al.  Identification of CREB3L1 as a Biomarker Predicting Doxorubicin Treatment Outcome , 2015, PloS one.

[24]  T. Gajewski,et al.  The STING pathway and the T cell-inflamed tumor microenvironment. , 2015, Trends in immunology.

[25]  Michael Rose,et al.  OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro , 2014, Epigenetics.

[26]  M. Seshadri,et al.  CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells , 2014, The Journal of Immunology.

[27]  M. Delorenzi,et al.  Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy , 2014, Nature Medicine.

[28]  C. Breitbach,et al.  Going viral with cancer immunotherapy , 2014, Nature Reviews Cancer.

[29]  B. Calvert,et al.  CREB3L1 Is a Metastasis Suppressor That Represses Expression of Genes Regulating Metastasis, Invasion, and Angiogenesis , 2013, Molecular and Cellular Biology.

[30]  I. McNeish,et al.  Vaccinia Virus Induces Programmed Necrosis in Ovarian Cancer Cells , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  J. Rauh-Hain,et al.  Recurrent epithelial ovarian cancer: an update on treatment. , 2013, Oncology.

[32]  M. Seshadri,et al.  Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases , 2013, Proceedings of the National Academy of Sciences.

[33]  B. Denard,et al.  Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1 , 2012, eLife.

[34]  F. Urano,et al.  Activation of OASIS family, ER stress transducers, is dependent on its stabilization , 2012, Cell Death and Differentiation.

[35]  J. Lišková,et al.  Apoptosis and necrosis in vaccinia virus-infected HeLa G and BSC-40 cells. , 2011, Virus research.

[36]  B. Denard,et al.  The membrane-bound transcription factor CREB3L1 is activated in response to virus infection to inhibit proliferation of virus-infected cells. , 2011, Cell host & microbe.

[37]  R. Eisenberg,et al.  Role of sulfatide in vaccinia virus infection , 2011, Biology of the cell.

[38]  Orla Maguire,et al.  Quantifying nuclear p65 as a parameter for NF‐κB activation: Correlation between ImageStream cytometry, microscopy, and Western blot , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[39]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[40]  A. Bowie,et al.  IFI16 is an innate immune sensor for intracellular DNA , 2010, Nature Immunology.

[41]  L. Zitvogel,et al.  Viral strategies for the evasion of immunogenic cell death , 2010, Journal of internal medicine.

[42]  D. Sze,et al.  Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial. , 2008, The Lancet. Oncology.

[43]  Roy Parker,et al.  RNA Quality Control in Eukaryotes , 2007, Cell.

[44]  G. Schuler,et al.  The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti‐tumoral immunity , 2006, Clinical and experimental immunology.

[45]  B. Moss,et al.  The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2. , 2005, Cancer research.

[46]  S. Libutti,et al.  Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes. , 2001, Cancer research.

[47]  T. Tsukamoto,et al.  Identification of a novel gene, OASIS, which encodes for a putative CREB/ATF family transcription factor in the long-term cultured astrocytes and gliotic tissue. , 1999, Brain research. Molecular brain research.

[48]  Robert B Sim,et al.  Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  N. Blake,et al.  Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. , 1995, Virology.

[50]  R. Doms,et al.  Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks , 1993, The Journal of cell biology.

[51]  K. Odunsi,et al.  DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer. , 2007, Cancer immunity.